Market Place
Sourcing Support
Spexis announces promising data with balixafortide with various therapies
13 Dec 2022 //
GLOBENEWSWIRE
Spexis announces promising pre-clinical data with balixafortide in combination
13 Dec 2022 //
GLOBENEWSWIRE
Spexis announces positive renal impairment trial results with balixafortide
22 Sep 2022 //
GLOBENEWSWIRE
Polyphor provides update on the future of the FORTRESS study of balixafortide
19 Jul 2021 //
BLOOMBERG
Polyphor Provides Update on the Phase III FORTRESS Study of Balixafortide
28 Jun 2021 //
GLOBENEWSWIRE
Polyphor flops a phase 3, jeopardizing its future
28 Jun 2021 //
FIERCEBIOTECH
Polyphor Announces Third Positive Data Safety Monitoring Board (DSMB)
14 Dec 2020 //
GLOBENEWSWIRE
Polyphor completes recruitment in Phase III trial of balixafortide
30 Oct 2020 //
PHARMIWEB
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.